3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
5
Myeloid
5
Plasma cell
1
Lymphoid
1
Classical hematology
1
Conditions
Anemia, Refractory, with Excess of Blasts
62
Leukemia, Myeloid, Acute
51
Myelodysplastic Syndromes
39
Leukemia
37
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
Leukemia, Myelomonocytic, Chronic
34
Leukemia, Lymphocytic, Chronic, B-Cell
26
Blast Crisis
23
Myeloproliferative Disorders
20
Congenital Abnormalities
20
Multiple Myeloma
17
Anemia, Refractory
15
Myelodysplastic-Myeloproliferative Diseases
14
Hodgkin Disease
14
Anemia
14
Primary Myelofibrosis
13
Lymphoma
13
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
13
Lymphoma, Non-Hodgkin
12
Leukemia, Myeloid, Chronic-Phase
12
Thrombocytopenia
11
Neoplasms, Plasma Cell
11
Lymphoma, Mantle-Cell
11
Leukemia, Myeloid, Accelerated Phase
11
Lymphoma, Large-Cell, Immunoblastic
10
Lymphoma, Large B-Cell, Diffuse
10
Hematologic Neoplasms
10
Burkitt Lymphoma
10
Lymphoma, Follicular
9
Leukemia, Prolymphocytic
8
Interventions
Sertraline
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Preleukemia
×
Classical hematology
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled